| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/02/2005 | WO2004073590A3 Diagnostics and therapeutics for deseases associated with g-protein coupled receptor prostaglandin f2-alpha (prostaglandin f2-alpha) |
| 06/02/2005 | WO2004070003A3 Methods for selecting and screening for trasformants |
| 06/02/2005 | WO2004065567A3 Brain progenitor cell-based assay, and related methods and compositions |
| 06/02/2005 | WO2004062462A9 Monclonal anitbodies to rna binding protein gw182 |
| 06/02/2005 | WO2004058325A3 Ion channels as targets for sleep-related drugs |
| 06/02/2005 | WO2004058154A3 Method of identifying therapeutic agents |
| 06/02/2005 | WO2004052918A3 Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides |
| 06/02/2005 | WO2004041212A3 Apkc isoforms in nervous system disorders and cancer |
| 06/02/2005 | WO2004031358A3 Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof |
| 06/02/2005 | WO2004027034A3 Methods for assessing the ability of hiv patients to restrict hiv replication |
| 06/02/2005 | WO2004022576A3 Short peptides from the '2nd loop' of 7 transmembrane receptor which selectively modulate signal transduction |
| 06/02/2005 | WO2003073909A3 Assays to monitor levels of epidermal growth factor receptor (egfr) extracellular domain (ecd) in cancer patients |
| 06/02/2005 | WO2003068932A8 Method for crystallizing human gsk3 and novel crystal structure thereof |
| 06/02/2005 | WO2003059253A3 Compositions and methods for altering glucose production |
| 06/02/2005 | US20050120393 Nucleotide sequences associated with prostate specific gene expression for use as tool in diagnosis, prognosis, classification, prevention and treatment of cell proliferative disorders of urogenital systems |
| 06/02/2005 | US20050119869 Annotation method |
| 06/02/2005 | US20050119866 Medical parameter processing system |
| 06/02/2005 | US20050119835 Method and apparatus for analysis of molecular combination based on computational estimation of electrostatic affinity using basis expansions |
| 06/02/2005 | US20050119834 Method and apparatus for analysis of molecular combination based on computations of shape complementarity using basis expansions |
| 06/02/2005 | US20050119832 Computer system and method for calculating adme properties |
| 06/02/2005 | US20050119589 Rapid sample collection and analysis device and methods of use |
| 06/02/2005 | US20050119550 System and methods for screening a luminal organ ("lumen viewer") |
| 06/02/2005 | US20050119540 Methods and devices for prediction of hypoglycemic events |
| 06/02/2005 | US20050119536 Diagnostics and therapeutics for arterial wall disruptive disorders |
| 06/02/2005 | US20050119534 Method for predicting the onset or change of a medical condition |
| 06/02/2005 | US20050119477 Method for determining specific groups constituting heparins or low molecular weight heparins |
| 06/02/2005 | US20050119461 Which have affinity for oxazoline compounds; for treatment of glaucoma, dementia, mood disturbances, degenerative conditions, and neurodegenerative diseases |
| 06/02/2005 | US20050119457 Human proteins |
| 06/02/2005 | US20050119455 Polypeptide fusion comprising complementary determining regions for use as tool in immunotherapeutic and/or diagnostics; bioassay |
| 06/02/2005 | US20050119415 High capacity assay platforms |
| 06/02/2005 | US20050119387 Magnetically detectable latex articles |
| 06/02/2005 | US20050119210 Using genes encoding transmembrane protein as markers; targets for cancer therapy; drug screening |
| 06/02/2005 | US20050119206 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 06/02/2005 | US20050119182 Bioassay; detect compound as antigonist; antiserotonine agents |
| 06/02/2005 | US20050119174 Novel blood sugar controller and method of screening the same |
| 06/02/2005 | US20050119173 Novel potassium-dependent sodium-calcium exchanger |
| 06/02/2005 | US20050119171 Forsenic analysis; medical diagnosis; chromosome markers |
| 06/02/2005 | US20050118732 Immunoassay method for lyzed whole blood |
| 06/02/2005 | US20050118731 Method and apparatus using a surface-selective nonlinear optical technique for detection of probe-target interactions without labels |
| 06/02/2005 | US20050118730 Microchannel array component, microchannel array for recovering biomolecules, and method for recovering biomolecules |
| 06/02/2005 | US20050118729 Microarrays of cellulose binding chimeric proteins and methods of use thereof |
| 06/02/2005 | US20050118728 Two-layer antibody capture system |
| 06/02/2005 | US20050118727 Conjugates and their use in detection methods |
| 06/02/2005 | US20050118726 System and method for detecting bioanalytes and method for producing a bioanalyte sensor |
| 06/02/2005 | US20050118723 Using polarized light to classify white blood cell populations; miniaturized portable and wearable cytometer; detection infection |
| 06/02/2005 | US20050118722 Reagents for arsenic meter |
| 06/02/2005 | US20050118720 Using mass spectrum analysis and liquid chromatography to detect and sequences animal protein materials; diagnosis of spongiform encephalopathy |
| 06/02/2005 | US20050118709 High capacity assay platforms |
| 06/02/2005 | US20050118708 Cover for a hybridization chamber |
| 06/02/2005 | US20050118696 Methods and means for modulating PGE synthase activity |
| 06/02/2005 | US20050118671 Analysis of vital substances |
| 06/02/2005 | US20050118668 Non-radioactive label fluorophore covalently bonded to a modified tyrosine residue |
| 06/02/2005 | US20050118666 Method of assaying coenzymes a in biological sample |
| 06/02/2005 | US20050118663 Identifying an agent that modulates serine hydroxymethyltransferase (SHMT) activity by assaying biological activity of p38 in the presence of test agents to identify those that modify p38, and testing those agents for their ability to modulate enzymatic activity of SHMT; use as antiproliferative agents |
| 06/02/2005 | US20050118662 Analytical sandwich test for determining NT-proBNP |
| 06/02/2005 | US20050118661 Fibronectin variants and screening methods |
| 06/02/2005 | US20050118660 Using lipoprotein (LP1) specific monoclonal antibody to detect pseudomonas infection; bioassay |
| 06/02/2005 | US20050118658 Use of ERRalpha phosphorylation status as a breast cancer biomarker |
| 06/02/2005 | US20050118657 Using peptide yy concentration as diagnostic tool in detection/prognosis cell proliferative disorders of colon |
| 06/02/2005 | US20050118656 Methods for diagnosis and treatment of epithelial-derived cancers |
| 06/02/2005 | US20050118655 Using helminth mixture as therapeutic tool in treatment of autoimmune and allergic disorders; antihelmintics |
| 06/02/2005 | US20050118654 Hemoglobin assay for neonatal screening |
| 06/02/2005 | US20050118653 Determining hemostatic competence of blood by contacting blood sample with an effective amount of tissue factor to coagulate blood, and determinig amount of thrombin in blood sample at a prdetermined time point, where amount of thrombin is indicative of the hemostatic competence |
| 06/02/2005 | US20050118652 Rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method |
| 06/02/2005 | US20050118651 Immunoglobulin light chain comprising variable complementarity determining regions (CDRs) for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy; immunodiagnostics |
| 06/02/2005 | US20050118650 Fourier transform mass spectrometry of complex biological samples |
| 06/02/2005 | US20050118649 Monitoring protein translocation into preferential cellular compartment via reporter expression of fluorescent protein fusion |
| 06/02/2005 | US20050118645 Prion specific immunogllobulin for detection, diagnosis and prevention of spongiform encephalopathies; immunotherapy |
| 06/02/2005 | US20050118644 Using interaction between n-methyl-d-aspartate receptor (NMDA-R) protein tyrosine kinase to identify modulator for prevention and treatment of nervous system, brain, cardiovascular and alcohol disorders |
| 06/02/2005 | US20050118643 Specific binding agents to hepatocyte growth factor |
| 06/02/2005 | US20050118642 Homogeneous detection method |
| 06/02/2005 | US20050118641 Quantitative analysis; for stabilization of insulin forms |
| 06/02/2005 | US20050118639 Using fluorescent protein reporting to identify interaction between receptor binding agent and orphan receptor; immunoassay |
| 06/02/2005 | US20050118638 Using thyrotrophin (TSH) receptor as diagnostic tool in detection of autoimmune diseases; competive binding assay |
| 06/02/2005 | US20050118637 Automated mass spectroscopy, HPLC, UV spectroscopy, fluorescence spectroscopy, gas chromatography, optical density, and colorimetry |
| 06/02/2005 | US20050118636 Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state |
| 06/02/2005 | US20050118635 Using cytoskeletal membrane protein concentration as diagnostic indicator of cell proliferative disorders; antitumor agents |
| 06/02/2005 | US20050118631 Fluorescent semiconductor nanocrystals; spectral emission provides information about a biological state or event |
| 06/02/2005 | US20050118628 Synthesizing polynucleotide sequences based on model generated sequences; bioinformatics; directed evolution of proteins |
| 06/02/2005 | US20050118624 Anitbiotic ligand and fluorophore; for high throughput screening |
| 06/02/2005 | US20050118622 Methods for predicting development of insulin resistance |
| 06/02/2005 | US20050118620 Using fluorescent data from cyclic amplification to determine concentration of DNA in sample; polymerase chain reaction propagation analysis |
| 06/02/2005 | US20050118619 Dark quenchers for fluorescence resonance energy transfer (FRET) in bioassays |
| 06/02/2005 | US20050118617 Solid phase synthesis; microarrays |
| 06/02/2005 | US20050118614 Compositions and methods using eukaryotic Rad5 |
| 06/02/2005 | US20050118612 Methods and systems for applying genetic operators to determine system conditions |
| 06/02/2005 | US20050118604 Modulators of angiogenesis and tumorigenesis |
| 06/02/2005 | US20050118600 Improved efficiency of cancer drugs based on gene expression; enzyme inhibitors; microarrays, probes, primers, animal models; PCR kits |
| 06/02/2005 | US20050118596 Using fos-related antigen 1 (FRA-1) gene expression as diagnostic indicator of histone deacetylase (HDAC) inhibition; antitumor agents |
| 06/02/2005 | US20050118595 Fabrication of surfaces with reduced protein adsorption and/or cell adhesion |
| 06/02/2005 | US20050118591 Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer |
| 06/02/2005 | US20050118589 Digital array |
| 06/02/2005 | US20050118587 Method and kit for detection of novel pathogen inhibitors |
| 06/02/2005 | US20050118586 Expression vector comprising nucleotide sequences coding heterologous polypeptide for use in forensic analysis as chromosome, tissue, cell and organelle specific markers |
| 06/02/2005 | US20050118585 Using allelic variation in bone morphogenic signaling family proteins as diagnostic tool in detection of vision defcets |
| 06/02/2005 | US20050118575 Immune cell polypeptide for use in diagnosis and treatment of cell proliferative disorders |
| 06/02/2005 | US20050118574 based on fluorescence emission intensity; flow cytometry; immunoassay |
| 06/02/2005 | US20050118572 Separating virally infected viable cells from dead cells via antibody staining and nucleic acid labeling; monitoring effectiveness of viricidal therapies |
| 06/02/2005 | US20050118570 Using magnetic or paramagnetic substrates to separate biological targets from gaseous, liquid and solid samples |
| 06/02/2005 | US20050118569 Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to venezuelan equine encephalitis virus |